Resmed Inc. buy UBS Group AG
Start price
12.12.25
/
50%
€214.10
Target price
12.12.26
-
Performance (%)
-2.62%
Price
30.12.25
€208.50
Summary
This prediction is currently active. With a performance of -2.62%, the BUY prediction by UBS_Group_AG is trending in the wrong direction. This prediction currently runs until 12.12.26. The prediction end date can be changed by UBS_Group_AG at any time. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Resmed Inc. | 0.530% |
| iShares Core DAX® | 0.794% |
| iShares Nasdaq 100 | 0.016% |
| iShares Nikkei 225® | 0.309% |
| iShares S&P 500 | 0.181% |
Comments by UBS_Group_AG for this prediction
In the thread Resmed Inc. diskutieren
ResMed (NYSE:RMD) had its "buy" rating reaffirmed by analysts at UBS Group AG.
Ratings data for RMD provided by MarketBeat